Public Health Service of Amsterdam
11
0
2
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
18.2%
2 terminated/withdrawn out of 11 trials
75.0%
-11.5% vs industry average
9%
1 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
VAT-2: Evaluation of a Virtual Antimicrobial Stewardship Team (VAT) on Antibiotic Prescriptions in Nursing Homes
Role: lead
E-Health for Zero Infections - Facilitating Access to and Use of HIV Pre-Exposure Prophylaxis (PrEP) in the Netherlands
Role: lead
Interventions to Curb Hepatitis C Reinfections Among Men Who Have Sex With Men
Role: lead
Comorbidity and Aging With HIV
Role: collaborator
Clinical, Virological, Immunological, Psychosocial and Epidemiological Consequences of Human Monkeypox Virus (ProMPX)
Role: lead
New AntiBiotic Treatment Options for Uncomplicated Anogenital GOnorrhoea
Role: lead
A SYNdemic BASed INtervention for MSM With High Risk Behavior: Design of a Randomized Controlled Trial
Role: lead
Transmission of Genital and Extra-genital Chlamydia Trachomatis Infections in Women
Role: collaborator
Disinvestment Study of Population-Based Vision Screening in Children
Role: collaborator
Cohort of Hepatitis B Research of Amsterdam
Role: lead
Effect Study of a Theory-Based Internet Intervention on Safe-Sex Practices
Role: lead
All 11 trials loaded